BackDoximity Overview
Doximity Inc - Ordinary Shares - Class A

Doximity Target Price

Analysts' average 12-month price target for Doximity is $34.

Get informed when a big investor buys or sells

+ Follow

Share Price

$32.42

Average Target Price

$33.884.5% upside

8 analysts in the last 4 months

High: $41 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-16Raymond JamesBrian Peterson$3817.2% upsideOpen
2026-09-29Evercore ISIElizabeth Anderson$358% upsideOpen
2026-09-08Stifel Nicolaus$2716.7% downsideOpen
2026-08-13Truist FinancialJailendra Singh$2426% downsideOpen
2026-08-07NeedhamScott Berg$4126.5% upsideOpen
2026-08-07BMO Capital$307.5% downsideOpen
2026-08-07Canaccord Genuity$3611% upsideOpen
2026-08-07Evercore ISIElizabeth Anderson$4023.4% upsideOpen
2026-05-14Morgan StanleyCraig Hettenbach$358% upsideOpen
2026-05-14Leerink PartnersMichael Cherny$2522.9% downsideOpen
2026-05-14Jefferies$1941.4% downsideOpen
2026-05-14Robert W. BairdVikram Kesavabhotla$1844.5% downsideOpen
2026-05-14Wells Fargo$1844.5% downsideOpen
2026-05-14Barclays$2038.3% downsideOpen
2026-05-14Truist FinancialJailendra Singh$1941.4% downsideOpen
2026-05-14BMO CapitalSean Dodge$2038.3% downsideOpen
2026-05-14NeedhamScott Berg$2716.7% downsideOpen
2026-05-14Mizuho Securities$2619.8% downsideOpen
2026-05-14Canaccord Genuity$307.5% downsideOpen
2026-05-14Goldman Sachs$2426% downsideOpen
2026-05-11Wells Fargo$321.3% downsideOpen
2026-04-20Truist Financial$2910.5% downsideOpen
2026-03-17Loop Capital MarketsGene Mannheimer$314.4% downsideOpen
2026-02-20Piper Sandler$4229.5% upsideOpen
2026-02-09Canaccord GenuityRichard Close$344.9% upsideOpen
2026-02-06KeyBanc$3817.2% upsideOpen
2026-02-06Truist FinancialJailendra Singh$3714.1% upsideOpen
2026-02-06Goldman Sachs$344.9% upsideOpen
2026-02-06Morgan Stanley$4951.1% upsideOpen
2026-02-06BMO Capital$2522.9% downsideOpen
2026-02-06BTIGDavid Larsen$5054.2% upsideOpen
2026-02-06NeedhamScott Berg$5569.6% upsideOpen
2026-02-06Piper SandlerJessica Tassan$4023.4% upsideOpen
2026-02-06Wells Fargo$4538.8% upsideOpen
2026-02-04Mizuho Securities$4538.8% upsideOpen
2026-01-20Wells FargoStan Berenshteyn$5569.6% upsideOpen
2026-01-09Goldman SachsDavid Roman$4951.1% upsideOpen
2026-01-08RBC Capital$5982% upsideOpen
2026-01-08Truist FinancialJailendra Singh$6291.2% upsideOpen
2026-01-08KeyBanc$6085.1% upsideOpen
2026-01-08Canaccord GenuityRichard Close$4848.1% upsideOpen
2026-01-08Canaccord Genuity$5054.2% upsideOpen
2025-12-15Morgan Stanley$65100.5% upsideOpen
2025-12-08BarclaysGlen Santangelo$6394.3% upsideOpen
2025-10-08Evercore ISI$81149.8% upsideOpen
2025-10-08KeyBancScott Schoenhaus$80146.8% upsideOpen
2025-10-01Goldman SachsDavid Roman$6497.4% upsideOpen
2025-09-18Canaccord GenuityRichard Close$67106.7% upsideOpen
2025-09-10Raymond James$75131.3% upsideOpen
2025-05-20Goldman SachsDavid Roman$5054.2% upsideOpen

Doximity (DOCS) FAQ

Doximity (DOCS) currently reports a target price of $34. Use the charts on this page to explore Doximity's target price history and peer comparisons.

Analysts' average 12-month price target for Doximity is $34, about 4.5% upside from the current share price of $32.42. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $34, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Doximity, and consider following DOCS for alerts when major investors trade the stock.

Doximity is classified in the Healthcare sector. On target price, it currently shows $34. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DOCS with unrelated industries.